![Grünenthal Group](/data/images/public/13560264/13962929/ea0433fc-7763-4288-933f-8476b13b6147-w_360_h_52.png)
Grünenthal announces significant investments in its Latin America production sites, further securing reliable medicine supply for patients17.7.2024 10:30:02 CEST | Grünenthal Group
Investment of more than €80 million to modernise Latin American production sites. In Santiago de Chile, a 3,500-square-metre solids plant has been completely refurbished, creating a world-class manufacturing facility with a production capacity of 1.8 billion tablets annually. In Quito, Ecuador, a new 1,800-square-metre plant will enable the production of 300 million high-quality tablets annually for pain patients in 17 European countries.